Yvonne Burazer

Takeda Manufacturing Austria
Global Process Expert for Paperless Validation, Global Engineering
Yvonne Burazer is the Global SME and Business Process Owner for Paperless Validation at Takeda, with over 19 years of experience in the biopharmaceutical industry, including 17 years in validation-focused roles such as quality validation, manufacturing, and engineering. She played a key role in the global rollout of a paperless validation system. Yvonne holds a bachelor’s degree in international business and engineering and a master’s degree in innovation and technology management from the UAS Technikum Vienna. She has been an ISPE member since 2023.

Related Articles

Digital Commissioning, Qualification, and Validation in Large Capital Projects
Features
Digital Commissioning, Qualification, and Validation in Large Capital Projects

In today’s pharmaceutical landscape, speed, compliance, and efficiency are no longer optional—they’re strategic imperatives. Yet for large capital expenditure (CapEx) projects, traditional paper-based commissioning, qualification, and validation (CQV) workflows remain a major bottleneck, consuming time, resources, and patience.

ai-technology-microchip-background-digital-transformation-concept-750px
iSpeak Blog
Scaling AI in Pharma: From Adoption to Sustainable Impact
The authors have explored how a shift in organizational culture can transform AI from a mere technical tool into a true collaborative partner, enhancing human expertise and driving innovation. The authors have also shared how AI is revolutionizing quality assurance throughout the pharmaceutical manufacturing lifecycle, from raw material intake to predictive maintenance, delivering greater...
AI-Image by Aristal Branson from Pixabay
iSpeak Blog
Enhancing Pharmaceutical Quality Through AI

Pharmaceutical manufacturing faces mounting pressure to comply with stringent regulatory requirements while maintaining the highest standards of quality, speed, and efficiency. As digital transformation revolutionizes industries, artificial intelligence (AI) is emerging as a critical driver of change in reshaping how pharmaceutical companies operate. This article continues our exploration of...

iSpeak
iSpeak Blog
Embracing Cultural Change: AI as a Collaborator in Pharma
This article explores what it takes to build a culture where human expertise and artificial intelligence complement one another, driving speed, precision, and innovation without sacrificing regulatory rigor.